OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of DMT on mental health outcomes in healthy volunteers
Christopher Timmermann, Richard J. Zeifman, David Erritzøe, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Christopher Timmermann, Richard J. Zeifman, David Erritzøe, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
Yuan Yao, Dan Guo, Tangsheng Lu, et al.
Psychiatry Research (2024) Vol. 335, pp. 115886-115886
Closed Access | Times Cited: 23
Yuan Yao, Dan Guo, Tangsheng Lu, et al.
Psychiatry Research (2024) Vol. 335, pp. 115886-115886
Closed Access | Times Cited: 23
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression
Johannes G. Ramaekers, Johannes T. Reckweg, Natasha L. Mason
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 33-46
Closed Access | Times Cited: 1
Johannes G. Ramaekers, Johannes T. Reckweg, Natasha L. Mason
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 33-46
Closed Access | Times Cited: 1
Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)
Max Wolff, Ricarda Evens, Lea J. Mertens, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 432-457
Open Access | Times Cited: 6
Max Wolff, Ricarda Evens, Lea J. Mertens, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 432-457
Open Access | Times Cited: 6
Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being
Valérie Bonnelle, Amanda Feilding, Fernando E. Rosas, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 10, pp. 887-896
Open Access | Times Cited: 4
Valérie Bonnelle, Amanda Feilding, Fernando E. Rosas, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 10, pp. 887-896
Open Access | Times Cited: 4
N, N-dimethyltryptamine (DMT) in rodent brain: Concentrations, distribution, and recent pharmacological data
Steven A. Barker
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111259-111259
Closed Access
Steven A. Barker
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111259-111259
Closed Access
Serotonergic psychedelics as potential therapeutics for post-COVID-19 syndrome (or Long COVID): A comprehensive review
Zhen Xuen Brandon Low, Shin Jie Yong, Hayam A Alrasheed, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111279-111279
Closed Access
Zhen Xuen Brandon Low, Shin Jie Yong, Hayam A Alrasheed, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111279-111279
Closed Access
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, et al.
Advanced Science (2025)
Open Access
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, et al.
Advanced Science (2025)
Open Access
Interrupting the Psychedelic Experience Through Contextual Manipulation to Study Experience Efficacy
Leor Roseman, David Erritzøe, David Nutt, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2422181-e2422181
Open Access | Times Cited: 3
Leor Roseman, David Erritzøe, David Nutt, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2422181-e2422181
Open Access | Times Cited: 3
Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects
Charlotte Martial, Robin Carhart‐Harris, Christopher Timmermann
Neuroscience of Consciousness (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 2
Charlotte Martial, Robin Carhart‐Harris, Christopher Timmermann
Neuroscience of Consciousness (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 2
Autonomic Nervous System activity correlates with peak experiences induced by DMT and predicts increases in wellbeing
Valérie Bonnelle, Amanda Feilding, Fernando E. Rosas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Valérie Bonnelle, Amanda Feilding, Fernando E. Rosas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A dual-receptor model of serotonergic psychedelics
Arthur Juliani, Veronica Chelu, Laura Graesser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Arthur Juliani, Veronica Chelu, Laura Graesser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Exploring Endogenous Tryptamines: Overlooked Agents Against Fibrosis in Chronic Disease? A Narrative Review
Hunter Korsmo
Livers (2024) Vol. 4, Iss. 4, pp. 615-637
Open Access
Hunter Korsmo
Livers (2024) Vol. 4, Iss. 4, pp. 615-637
Open Access
Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants
Livio Erne, Severin B. Vogt, Lorenz Müller, et al.
Neuropsychopharmacology (2024)
Open Access
Livio Erne, Severin B. Vogt, Lorenz Müller, et al.
Neuropsychopharmacology (2024)
Open Access
Plant-derived compounds and neurodegenerative diseases: Different mechanisms of action with therapeutic potential
Carolina Echeverry, Mariana Pazos, Maximiliano Torres-Pérez, et al.
Neuroscience (2024)
Closed Access
Carolina Echeverry, Mariana Pazos, Maximiliano Torres-Pérez, et al.
Neuroscience (2024)
Closed Access
